CYP1B1 rs121908737: What Your Genotype Means
The rs121908737 variant is a rare genetic change in the CYP1B1 gene. It is primarily studied for its association with primary congenital glaucoma, a condition that affects the development of the eye's drainage system.
What each genotype means
Typical risk profile
You carry two copies of the common reference allele at this position in the CYP1B1 gene. Research indicates this genotype is associated with normal CYP1B1 enzyme activity and does not elevate your risk for primary congenital glaucoma. No special monitoring related to this specific variant is indicated.
Found in well over 99% of individuals across nearly all global ancestral populations.
Glaucoma carrier status
You carry one copy of the pathogenic missense variant linked to impaired CYP1B1 enzyme function. Because primary congenital glaucoma follows an autosomal recessive inheritance pattern, heterozygous carriers typically do not develop the condition but can pass the altered allele to biological offspring. Reproductive implications may be discussed with a genetic counselor, particularly if a partner shares Middle Eastern or Slovakian Roma ancestry where carrier frequencies are higher.
Carried by fewer than 1 in 1,000 individuals worldwide, but reaches higher frequencies in certain Middle Eastern and Slovakian founder populations.
Elevated congenital glaucoma risk
You carry two copies of this pathogenic variant, which causes severe disruption of the CYP1B1 enzyme essential for normal ocular drainage structure development. In clinical studies, this homozygous genotype is strongly associated with early-onset primary congenital glaucoma inherited in an autosomal recessive manner. Clinical evaluation by an ophthalmologist or clinical geneticist is typically recommended to assess ocular health.
Extremely rare in the general global population, occurring almost exclusively in specific founder communities or consanguineous families.
Understanding the rs121908737 Variant
The rs121908737 variant is a specific change in the DNA sequence of the CYP1B1 gene. In genetics, a variant like this is often referred to as a missense mutation, meaning it causes a single building block of the protein, known as an amino acid, to be replaced by another. This alteration can change the shape or function of the resulting protein. The rs121908737 variant is located within the coding region of the gene, which provides the instructions for building the cytochrome P450 1B1 enzyme. Because this enzyme plays a critical role in various biological processes, changes to its structure can have downstream effects on cellular health. Researchers track these specific locations in the genome using an rsID, or reference SNP cluster ID, to ensure they are discussing the exact same genetic position across different studies and populations.
The Role of the CYP1B1 Gene
The CYP1B1 gene provides instructions for making an enzyme that belongs to the cytochrome P450 family. These enzymes are primarily known for their role in metabolizing substances, including drugs, steroids, and other lipids within the body. Beyond metabolism, the CYP1B1 enzyme is essential for the normal development of the eye, particularly the trabecular meshwork, which is the tissue responsible for draining fluid from the eye. When the CYP1B1 enzyme is not functioning correctly due to a genetic variant, it can lead to an imbalance in the eye's internal pressure. This pressure is a key factor in the development of primary congenital glaucoma. Because the gene is involved in such fundamental processes, researchers continue to study how different variants influence both eye development and the body's broader chemical processing capabilities.
Research and Clinical Associations
Scientific research has linked certain variants in the CYP1B1 gene to primary congenital glaucoma, an autosomal recessive condition. This means that an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to be at an increased risk for the condition. The evidence for rs121908737 specifically is categorized as limited in many clinical databases, meaning that while it is identified as a potential factor in glaucoma, more research is needed to fully understand its penetrance and expressivity. It is important to note that having a variant does not guarantee the development of a condition, as genetic, environmental, and other factors often interact in complex ways. Clinical studies often focus on families with a history of early-onset eye issues to better map how these specific genetic changes contribute to the disease process.
Population Frequency and Distribution
The rs121908737 variant is considered very rare on a global scale. Genetic studies indicate that its frequency is not uniform across all human populations. Instead, it appears more frequently in specific founder groups, such as certain populations in the Middle East and Slovakia. A founder effect occurs when a small group of people establishes a new population, leading to a higher prevalence of specific genetic variants that were present in the original group. Because of this, the likelihood of carrying this variant depends heavily on an individual's ancestral background. Researchers use large-scale genomic databases to estimate these frequencies, but because the variant is so rare, data can be sparse for many regions of the world, making it difficult to establish precise prevalence rates for every ethnic group.
Navigating Genetic Information
If you have received information about your status for the rs121908737 variant, it is essential to approach this data with the help of a qualified healthcare professional. Genetic information is complex, and a single variant rarely tells the whole story of an individual's health. You cannot use this information to diagnose yourself or others. If you are concerned about your risk for glaucoma or other conditions, consult with a genetic counselor or an ophthalmologist who can interpret your results in the context of your personal and family medical history. They can provide guidance on whether further testing or clinical monitoring is appropriate. Always remember that genetic testing is a tool for information, not a substitute for professional medical evaluation, and any decisions regarding your health should be made in partnership with your clinical care team.
How common is this variant?
The rs121908737 variant is very rare globally, though it shows a higher carrier frequency in specific Middle Eastern and Slovakian founder groups.
Frequently asked questions
What is primary congenital glaucoma?
Primary congenital glaucoma is a rare condition present at or shortly after birth that affects the eye's drainage system. It leads to increased pressure within the eye, which can damage the optic nerve if left untreated.
Does having the rs121908737 variant mean I will get glaucoma?
No, having a genetic variant does not mean you will definitely develop a condition. Genetic risk is complex, and many factors, including other genes and environmental influences, contribute to the development of glaucoma.
Should I get tested for this variant?
Genetic testing is usually recommended only if there is a family history of the condition or if a doctor suspects a genetic cause for symptoms. You should discuss the necessity of testing with a genetic counselor or your physician.
Is there a cure for conditions caused by CYP1B1 mutations?
While there is no cure for the underlying genetic mutation, primary congenital glaucoma is managed through medical and surgical interventions to lower eye pressure. Early detection and treatment are critical for preserving vision.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908737?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CYP1B1
This variant (p.Asn453Ser, formerly Val432Leu) in the CYP1B1 gene is associated with altered enzyme activity and has been investigated for susceptibility to various cancers, including breast and prostate cancer.
This variant (p.Gly61Glu) is a well-documented pathogenic mutation associated with primary congenital glaucoma (PCG) and is also studied for its role in oxidative stress and drug response pathways.
A missense variant in CYP1B1 (p.Ala119Ser) associated with primary congenital glaucoma and juvenile open-angle glaucoma risk.
A well-characterized loss-of-function missense variant causing primary congenital glaucoma through abnormal trabecular meshwork development.
Missense variant in CYP1B1 associated with primary congenital glaucoma.
A classic founder missense mutation in CYP1B1 responsible for early-onset recessive infantile and juvenile glaucoma.